Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Supportive care, Treatment				Active				18 and over				Other				001-0015-211 NCT00127387


2.		Etanercept Mouthwash to Treat Stomatitis and Oral Pain in Patients Receiving Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				16 and over				NINR				020133 02-NR-0133, NCT00031551

Last Modified: 1/1/2009 First Published: 3/24/2006


3.		Phase II Study of Etanercept in Pediatric Patients With Acute Noninfectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) After Undergoing Allogeneic Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				1 to 17				NCI				COG-ASCT0521 COG-PBMTC-SUP051, ASCT0521, NCT00309907


4.		Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				0 to 18				Other				2004-0215 NCT00509600

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute